Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

GlioblastomaBrain CancerBrain NeoplasmBrain TumorBrain Neoplasm, MalignantEGFR Gene OverexpressionGBM

Interventions

DRUG

Intra-arterial Cetuximab

DRUG

Intra-arterial Mannitol

Trial Locations (1)

RECRUITING

Lenox Hill Brain Tumor Center, New York